New York State Common Retirement Fund trimmed its holdings in shares of Omega Protein Co. (NYSE:OME) by 39.3% in the third quarter, HoldingsChannel.com reports. The firm owned 25,100 shares of the company’s stock after selling 16,280 shares during the period. New York State Common Retirement Fund’s holdings in Omega Protein were worth $418,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the stock. FMR LLC lifted its holdings in Omega Protein by 470.9% in the 2nd quarter. FMR LLC now owns 872,341 shares of the company’s stock worth $15,615,000 after buying an additional 719,541 shares in the last quarter. American Century Companies Inc. lifted its holdings in Omega Protein by 84.0% in the 3rd quarter. American Century Companies Inc. now owns 501,126 shares of the company’s stock worth $8,344,000 after buying an additional 228,707 shares in the last quarter. Shell Asset Management Co. acquired a new position in Omega Protein in the 3rd quarter worth $2,052,000. Prudential Financial Inc. lifted its holdings in Omega Protein by 151.3% in the 2nd quarter. Prudential Financial Inc. now owns 220,470 shares of the company’s stock worth $3,946,000 after buying an additional 132,750 shares in the last quarter. Finally, Fondren Management LP lifted its holdings in Omega Protein by 31.2% in the 2nd quarter. Fondren Management LP now owns 290,700 shares of the company’s stock worth $5,204,000 after buying an additional 69,140 shares in the last quarter. 85.81% of the stock is owned by hedge funds and other institutional investors.
Omega Protein Co. (NYSE OME) opened at $22.00 on Monday. Omega Protein Co. has a 1-year low of $14.50 and a 1-year high of $26.99. The company has a market cap of $494.54, a price-to-earnings ratio of 26.83 and a beta of 0.28.
Omega Protein (NYSE:OME) last issued its quarterly earnings data on Wednesday, November 8th. The company reported $0.09 EPS for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.22). Omega Protein had a return on equity of 6.48% and a net margin of 5.45%. The firm had revenue of $90.30 million during the quarter, compared to analyst estimates of $96.65 million. During the same quarter in the prior year, the firm earned $0.67 EPS. The business’s quarterly revenue was down 17.0% compared to the same quarter last year.
Separately, ValuEngine upgraded shares of Omega Protein from a “hold” rating to a “buy” rating in a report on Friday, December 1st.
WARNING: This piece was posted by Equities Focus and is the property of of Equities Focus. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this piece can be accessed at https://www.equitiesfocus.com/2018/01/08/new-york-state-common-retirement-fund-decreases-position-in-omega-protein-co-ome.html.
Omega Protein Company Profile
Omega Protein Corporation is a nutritional products company that develops, produces and delivers nutritious products. The Company operates through two segments: animal nutrition and human nutrition. The Company’s animal nutrition segment consists of two subsidiaries: Omega Protein, Inc (Omega Protein) and Omega Shipyard, Inc (Omega Shipyard).
Want to see what other hedge funds are holding OME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Protein Co. (NYSE:OME).
Receive News & Ratings for Omega Protein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Protein and related companies with MarketBeat.com's FREE daily email newsletter.